These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26814007)

  • 1. Catching Up on New Medications: New FDA Approvals.
    Turkoski BB
    Orthop Nurs; 2016; 35(1):39-42; quiz 43-4. PubMed ID: 26814007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More New Medication Approvals.
    Turkoski BB
    Orthop Nurs; 2016; 35(4):255-8. PubMed ID: 27441881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new? Medication changes 2008-2010.
    Turkoski BB
    Orthop Nurs; 2010; 29(5):344-7; quiz 348-9. PubMed ID: 20856091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
    Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
    [No Abstract]   [Full Text] [Related]  

  • 7. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals.
    Hao J; Rodriguez-Monguio R; Seoane-Vazquez E
    PLoS One; 2015; 10(10):e0140708. PubMed ID: 26469277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authorized Generic Drugs: an Overview.
    Gulsen Oner Z; Polli JE
    AAPS PharmSciTech; 2018 Aug; 19(6):2450-2458. PubMed ID: 29943278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic drug approval: a US perspective.
    Nagori BP; Mathur V; Garg S
    Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2020: A Record Year for Drug Approvals.
    Losben NL
    Sr Care Pharm; 2021 Apr; 36(4):174-175. PubMed ID: 33766189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jul; 74(143):37163-8. PubMed ID: 19655468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent drug approvals from the US FDA and EMEA: what the future holds.
    Pevarello P
    Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of risk evaluation and mitigation strategies and drug safety in the US.
    Rodriguez-Monguio R; Spielberger K; Seoane-Vazquez E
    Res Social Adm Pharm; 2014; 10(1):232-8. PubMed ID: 23611865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approach to generics may be a mixed blessing.
    Sipkoff M
    Manag Care; 2008 Feb; 17(2):20-1. PubMed ID: 18361252
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
    Kefalas CH; Ciociola AA
    Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves first celecoxib generics.
    Kuehn BM
    JAMA; 2014 Jun; 311(24):2470. PubMed ID: 25058066
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Oct; 24(10):684. PubMed ID: 20929413
    [No Abstract]   [Full Text] [Related]  

  • 20. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
    Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
    JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.